The first-line treatment for metastatic PC is androgen deprivation therapy (ADT) combined with an additional therapy such as an AR-signaling inhibitor (ARSI) and/or chemotherapy (Figure 1) [6]. This evidence concerns the gene AR and pachyonychia congenita.